. Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559

CD4+ Count–Guided Interruption of Antiretroviral Treatment

The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,250

CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract

Brenchley, J. M., Schacker, T. W., Ruff, L. E., Price, D. A., Taylor, J. H., Beilman, G. J., Nguyen, P. L., Khoruts, A., Larson, M. C., Haase, A. T., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040874 · Cited by 1,836

. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050203 · Cited by 1,617

Gastrointestinal Tract as a Major Site of CD4 + T Cell Depletion and Viral Replication in SIV Infection

Veazey, R. S., DeMaria, M. A., Chalifoux, L. V., Shvetz, D. E., Pauley, D. R., Knight, H., Rosenzweig, M., Johnson, R. P., Desrosiers, R. C., & Lackner, A. A. (1998) · Science · doi:10.1126/science.280.5362.427 · Cited by 1,404

LPS, TLR4 and infectious disease diversity

Miller, S., Ernst, R. K., & Bader, M. W. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1068 · Cited by 1,059

Shorter Survival in Advanced Human Immunodeficiency Virus Type 1 Infection Is More Closely Associated with T Lymphocyte Activation than with Plasma Virus Burden or Virus Chemokine Coreceptor Usage

Giorgi, J. V., Hultin, L. E., McKeating, J. A., Johnson, T. D., Owens, B. M., Jacobson, L. P., Shih, R., Lewis, J., Wiley, D. J., Phair, J. P., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314660 · Cited by 1,032

T Cell Activation Is Associated with Lower CD4+T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy

Hunt, P. W., Martin, J. N., Sinclair, E., Bredt, B. M., Hagos, E., Lampiris, H. W., & Deeks, S. G. (2003) · The Journal of Infectious Diseases · doi:10.1086/374786 · Cited by 852

Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load

Deeks, S. G., Ramirez, C. M., Liu, L., Guo, H., Gascon, R., Narváez, A. B., Hunt, P. W., Martin, J. N., Kahn, J. S., Levy, J. A., et al. (2004) · Blood · doi:10.1182/blood-2003-09-3333 · Cited by 803

Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral‐Treated HIV Infection

Jiang, W., Lederman, M. M., Hunt, P. W., Sieg, S. F., Haley, K. P., Rodriguez, B. A., LANDAY, A. L., Martin, J. N., Sinclair, E., Asher, A. I., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/597476 · Cited by 598

The effect of initiation of antiretroviral therapy on monocyte, endothelial and platelet function in HIV ‐1 infection

O’Halloran, J. A., Dunne, E., Gurwith, M., Lambert, J. S., Sheehan, G., Feeney, E. R., Pozniak, A., Reiss, P., Kenny, D. J., & Mallon, P. W. G. (2015) · HIV Medicine · doi:10.1111/hiv.12270 · Cited by 70

CD161+ MAIT Cells Are Severely Reduced in Peripheral Blood and Lymph Nodes of HIV-Infected Individuals Independently of Disease Progression

Eberhard, J. M., Hartjen, P., Kummer, S., Schmidt, R. E., Bockhorn, M., Lehmann, C., Balagopal, A., Hauber, J., van Lunzen, J., & Wiesch, J. S. Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111323 · Cited by 70

HIV-1 Infection of Human Intestinal Lamina Propria CD4+ T Cells In Vitro Is Enhanced by Exposure to Commensal Escherichia coli

Dillon, S. M., Manuzak, J. A., Leone, A. K., Lee, E. J., Rogers, L. M., McCarter, M. D., & Wilson, C. C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200681 · Cited by 71

Identifying Symptom Patterns in People Living With HIV Disease

Wilson, N., Azuero, A., Vance, D. E., Richman, J., Moneyham, L. D., Raper, J. L., Heath, S. L., & Kempf, M.-C. (2015) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2015.11.009 · Cited by 72

Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat

Wang, T., Yi, R., Green, L. A., Chelvanambi, S., Seimetz, M., & Clauss, M. A. (2015) · Cardiovascular Pathology · doi:10.1016/j.carpath.2015.07.001 · Cited by 69

Enhancement of HIV-1 infection and intestinal CD4+ T cell depletion ex vivo by gut microbes altered during chronic HIV-1 infection

Dillon, S. M., Lee, E. J., Donovan, A. M., Guo, K., Harper, M. S., Frank, D. N., McCarter, M. D., Santiago, M. L., & Wilson, C. C. (2016) · Retrovirology · doi:10.1186/s12977-016-0237-1 · Cited by 72

An Exploratory Trial of Cyclooxygenase Type 2 Inhibitor in HIV-1 Infection: Downregulated Immune Activation and Improved T Cell-Dependent Vaccine Responses

Pettersen, F. O., Torheim, E. A., Dahm, A. E. A., Aaberge, I. S., Lind, A., Meyer‐Myklestad, M. H., Aandahl, E. M., Sandset, P. M., Taskén, K., & Kvale, D. (2011) · Journal of Virology · doi:10.1128/jvi.00073-11 · Cited by 68

Immune activation during acute HIV infection and the impact of early antiretroviral therapy

Krebs, S. J., & Ananworanich, J. (2015) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000228 · Cited by 68

Managing HIV‐associated inflammation and ageing in the era of modern ART

Bloch, M. T., John, M., Smith, D. E., Rasmussen, T. A., & Wright, E. (2020) · HIV Medicine · doi:10.1111/hiv.12952 · Cited by 74

Dynamic alterations in monocyte numbers, subset frequencies and activation markers in acute and convalescent COVID-19 individuals

Rajamanickam, A., Kumar, N. P., Nancy, A., Selvaraj, N., Munisankar, S., Renji, R. M., Venkatramani, V., Murhekar, M. V., Thangaraj, J. W. V., Kumar, M. S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-99705-y · Cited by 67

Low Nadir CD4 Cell Count Predicts Sustained Hypertension in HIV‐Infected Individuals

Manner, I. W., Trøseid, M., Oektedalen, O., Bækken, M., & Os, I. (2012) · Journal of Clinical Hypertension · doi:10.1111/jch.12029 · Cited by 67

Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa

Kroeze, S., Ondoa, P., Kityo, C. M., Siwale, M., Akanmu, S. A., Wellington, M., de Jager, M., Ive, P., Mandaliya, K. N., Stevens, W. S., et al. (2018) · AIDS · doi:10.1097/qad.0000000000001801 · Cited by 67

Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial

Villar-García, J., Güerri‐Fernández, R., Moyá, A., González, A., Hernández, J. J., Lerma, E., Guelar, A., Sorlí, L., Horcajada, J. P., Artacho, A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173802 · Cited by 67

Aging, Health, and Quality of Life for Older People Living With HIV in Sub-Saharan Africa: A Review and Proposed Conceptual Framework

Siedner, M. J. (2017) · Journal of Aging and Health · doi:10.1177/0898264317724549 · Cited by 68

Progressive Proximal-to-Distal Reduction in Expression of the Tight Junction Complex in Colonic Epithelium of Virally-Suppressed HIV+ Individuals

Chung, C. Y., Alden, S. L., Funderburg, N., Fu, P., & Levine, A. D. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004198 · Cited by 67

Atorvastatin restricts HIV replication in CD4+ T cells by upregulation of p21

Elahi, S., Weiss, R. H., & Merani, S. (2015) · AIDS · doi:10.1097/qad.0000000000000917 · Cited by 65

Discordant Immune Response with Antiretroviral Therapy in HIV-1: A Systematic Review of Clinical Outcomes

Kelly, C., Gaskell, K. M., Richardson, M., Klein, N. J., Garner, P., & MacPherson, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156099 · Cited by 71

Circulating LPS and (1→3)-β-D-Glucan: A Folie à Deux Contributing to HIV-Associated Immune Activation

Ramendra, R., Isnard, S., Mehraj, V., Chen, J., Zhang, Y., Finkelman, M., & Routy, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00465 · Cited by 67

HIV and cardiovascular disease: the role of inflammation

Dirajlal‐Fargo, S., & Funderburg, N. (2022) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000755 · Cited by 65

Role of T‐Cell Dysfunction, Inflammation, and Coagulation in Microvascular Disease in HIV

Sinha, A., Ma, Y., Scherzer, R., Hur, S., Li, D., Ganz, P., Deeks, S. G., & Hsue, P. Y. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004243 · Cited by 68

Markers of microbial translocation predict hypertension in HIV ‐infected individuals

Manner, I. W., Bækken, M., Kvale, D., Oektedalen, O., Pedersen, M., Nielsen, S. D., Nowak, P., Os, I., & Trøseid, M. (2013) · HIV Medicine · doi:10.1111/hiv.12015 · Cited by 64

Microbial Translocation and Liver Disease Progression in Women Coinfected With HIV and Hepatitis C Virus

French, A. L., Evans, C. T., Agniel, D. M., Cohen, M. H., Peters, M. G., LANDAY, A. L., & Desai, S. N. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit225 · Cited by 64

Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers

Hoffmann, U., Lu, M. T., Olalere, D., Adami, E. C., Osborne, M. T., Ivanov, A. S., Aluru, J. S., Lee, S., Arifovic, N., Overton, E. T., et al. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.02.011 · Cited by 65

Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling

Giron, L. B., Peluso, M. J., Ding, J., Kenny, G., Zilberstein, N., Koshy, J., Hong, K. Y., Rasmussen, H. E., Miller, G. E., Bishehsari, F., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.160989 · Cited by 67

Distinct intestinal microbial signatures linked to accelerated systemic and intestinal biological aging

Singh, S. T., Giron, L. B., Shaikh, M. W., Shankaran, S., Engen, P. A., Bogin, Z. R., Bambi, S. A., Goldman, A. R., Azevedo, J. L. L. C., Orgaz, L., et al. (2024) · Microbiome · doi:10.1186/s40168-024-01758-4 · Cited by 63

Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first‐line combination antiretroviral therapy

Hattab, S., Guiguet, M., Carcelain, G., Fourati, S., Guihot, A., Autran, B., Caby, F., Marcelin, A., Costagliola, D. G., & Katlama, C. (2015) · HIV Medicine · doi:10.1111/hiv.12257 · Cited by 63

Association of Arterial and Lymph Node Inflammation With Distinct Inflammatory Pathways in Human Immunodeficiency Virus Infection

Tawakol, A. A., Ishai, A., Li, D., Takx, R. A. P., Hur, S., Kaiser, Y., Pampaloni, M. H., Rupert, A. W., Hsu, D. C., Sereti, I., et al. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.4728 · Cited by 63

Microbial Dysbiosis in Common Variable Immune Deficiencies: Evidence, Causes, and Consequences

Berbers, R.-M., Nierkens, S., van Laar, J. M., Bogaert, D., & Leavis, H. L. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.11.008 · Cited by 62

High Abundance of genus Prevotella in the gut of perinatally HIV-infected children is associated with IP-10 levels despite therapy

Sardarni, U. K., Shet, A., Rajnala, N., Gopalan, B. P., Moar, P., Himanshu, D., Singh, B. P., Chaturvedi, R., & Tandon, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-35877-4 · Cited by 60

Mechanisms of Cardiovascular Disease in the Setting of HIV Infection

Hsue, P. Y. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.12.024 · Cited by 64

Effect of Statin Therapy in Reducing the Risk of Serious Non-AIDS-Defining Events and Nonaccidental Death

Overton, E. T., Kitch, D. W., Benson, C. A., Hunt, P. W., Stein, J. H., Smurzynski, M., Ribaudo, H. J., & Tebas, P. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit053 · Cited by 62

Intestinal barrier dysfunction in HIV infection: pathophysiology, clinical implications and potential therapies

Assimakopoulos, S. F., Dimitropoulou, D., Marangos, M. N., & Gogos, C. A. (2014) · Infection · doi:10.1007/s15010-014-0666-5 · Cited by 61

Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study

Hattab, S., Guihot, A., Guiguet, M., Fourati, S., Carcelain, G., Caby, F., Marcelin, A., Autran, B., Costagliola, D. G., & Katlama, C. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-122 · Cited by 63

Autoimmunity and Inflammation in CVID: a Possible Crosstalk between Immune Activation, Gut Microbiota, and Epigenetic Modifications

Jørgensen, S. F., Fevang, B., & Aukrust, P. (2018) · Journal of Clinical Immunology · doi:10.1007/s10875-018-0574-z · Cited by 61

Relevance of biomarkers indicating gut damage and microbial translocation in people living with HIV

Ouyang, J., Yan, J., Zhou, X., Isnard, S., Harypursat, V., Cui, H., Routy, J., & Chen, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1173956 · Cited by 70

Long-term persistence of transcriptionally active ‘defective’ HIV-1 proviruses: implications for persistent immune activation during antiretroviral therapy

Singh, K., Natarajan, V., Dewar, R. L., Rupert, A. W., Badralmaa, Y., Zhai, T., Winchester, N., Scrimieri, F., Smith, M., Davis, I., et al. (2023) · AIDS · doi:10.1097/qad.0000000000003667 · Cited by 62

Potential Cardiovascular Disease Risk Markers Among HIV-Infected Women Initiating Antiretroviral Treatment

Kaplan, R. C., LANDAY, A. L., Hodis, H. N., Gange, S. J., Norris, P. J., Young, M., Anastos, K., Tien, P. C., Xue, X., Lazar, J., et al. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31825b03be · Cited by 60

Loss of Function of Intestinal IL-17 and IL-22 Producing Cells Contributes to Inflammation and Viral Persistence in SIV-Infected Rhesus Macaques

Ryan, E. S., Micci, L., Fromentin, R., Paganini, S., McGary, C. S., Easley, K. A., Chomont, N., & Paiardini, M. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005412 · Cited by 62

MMPs/TIMPs imbalances in the peripheral blood and cerebrospinal fluid are associated with the pathogenesis of HIV-1-associated neurocognitive disorders

Xing, Y., Shepherd, N., Lan, J., Li, W., Rane, S., Gupta, S. K., Zhang, S., Dong, J., & Yu, Q. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.04.024 · Cited by 61

Correlation Between Different Methods to Measure Microbial Translocation and Its Association With Immune Activation in Long-Term Suppressed HIV-1–Infected Individuals

Abad-Fernández, M., Vallejo, A., Hernández‐Novoa, B., Díaz, L., Gutiérrez, C., Madrid, N., Muñoz, M. Á., & Moreno, S. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31829a2f12 · Cited by 64

Accumulation of follicular CD8+ T cells in pathogenic SIV infection

Ferrando‐Martínez, S., Moysi, E., Pegu, A., Andrews, S. F., Nganou‐Makamdop, K., Ambrozak, D. R., McDermott, A. B., Palesch, D., Paiardini, M., Pavlakis, G. N., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96207 · Cited by 59

Examining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy

Ahmed, D., Roy, D., & Cassol, E. (2018) · Mediators of Inflammation · doi:10.1155/2018/6238978 · Cited by 62

Stunting Is Preceded by Intestinal Mucosal Damage and Microbiome Changes and Is Associated with Systemic Inflammation in a Cohort of Peruvian Infants

Zambruni, M., Ochoa, T. J., Somasunderam, A., Cabada, M. M., Morales, M. L., Mitreva, M., Rosa, B. A., Acosta, G. J., Vigo, N. I., Riveros, M., et al. (2019) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.18-0975 · Cited by 60

Effect of Solar Particle Event Radiation and Hindlimb Suspension on Gastrointestinal Tract Bacterial Translocation and Immune Activation

Zhou, Y., Ni, H., Li, M., Sanzari, J. K., Diffenderfer, E. S., Lin, L., Kennedy, A. R., & Weissman, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044329 · Cited by 60

Dynamics of Immune Reconstitution and Activation Markers in HIV+ Treatment-Naïve Patients Treated with Raltegravir, Tenofovir Disoproxil Fumarate and Emtricitabine

Funderburg, N., Andrade, A. S., Chan, E. S., Rosenkranz, S. L., Lu, D., Clagett, B. M., Pilch-Cooper, H. A., Rodriguez, B. A., Feinberg, J., Daar, E. S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083514 · Cited by 58

Higher levels of circulating monocyte–platelet aggregates are correlated with viremia and increased sCD163 levels in HIV-1 infection

Liang, H. L., Duan, Z., Li, D., Li, D., Wang, Z., Ren, L., Shen, T., & Shao, Y. (2014) · Cellular and Molecular Immunology · doi:10.1038/cmi.2014.66 · Cited by 58

Reduction of inflammation and T cell activation after 6 months of cART initiation during acute, but not in early chronic HIV-1 infection

de Paula, H. H. S., Ferreira, A. C. G., Caetano, D. G., Delatorre, E. O., Teixeira, S. L. M., Coelho, L. E., João, E. G., de Andrade, M. M., Cardoso, S. W., Grinsztejn, B. G. J., et al. (2018) · Retrovirology · doi:10.1186/s12977-018-0458-6 · Cited by 59

Higher cardiovascular disease risks in people living with HIV: A systematic review and meta-analysis

Zhu, S., Wang, W., He, J., Duan, W., Ma, X., Guan, H., Wu, Y., Li, S., Li, Y., Tian, T., et al. (2024) · Journal of Global Health · doi:10.7189/jogh.14.04078 · Cited by 59

Tumor Necrosis Factor α Is Associated With Viral Control and Early Disease Progression in Patients With HIV Type 1 Infection

Vaidya, S. A., Korner, C., Sirignano, M. N., Amero, M. A., Bazner, S., Rychert, J. A., Allen, T. M., Rosenberg, E. S., Bosch, R. J., & Altfeld, M. A. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu206 · Cited by 57

Interleukin-37: A crucial cytokine with multiple roles in disease and potentially clinical therapy (Review)

Wang, L., Quan, Y., Yue, Y., Heng, X., & Che, F. (2018) · Oncology Letters · doi:10.3892/ol.2018.7982 · Cited by 57

Anti-Retroviral Therapy Decreases but Does Not Normalize Indoleamine 2,3-Dioxygenase Activity in HIV-Infected Patients

Chen, J., Shao, J., Cai, R., Shen, Y., Zhang, R., Liu, L., Qi, T., & Lu, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100446 · Cited by 57

HIV Infection and Primary Prevention of Cardiovascular Disease: Lights and Shadows in the HAART Era

Ballocca, F., Gili, S., D’Ascenzo, F., Marra, W. G., Cannillo, M., Calcagno, A., Bonora, S., Flammer, A. J., Coppola, J., Moretti, C., et al. (2016) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2016.02.008 · Cited by 56

The Dual Role of Neutrophils in HIV Infection

Hensley‐McBain, T., & Klatt, N. R. (2018) · Current HIV/AIDS Reports · doi:10.1007/s11904-018-0370-7 · Cited by 84

Malnutrition in HIV-Infected Children Is an Indicator of Severe Disease with an Impaired Response to Antiretroviral Therapy

Muenchhoff, M., Healy, M., Singh, R., Roider, J., Groll, A., Kindra, C., Sibaya, T., Moonsamy, A., McGregor, C., Phan, M. Q., et al. (2017) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2016.0261 · Cited by 55

Lipopolysaccharide levels are elevated in dengue virus infected patients and correlate with disease severity

van de Weg, C. A. M., Koraka, P., Gorp, E. C. M. V., Mairuhu, A. T. A., Supriatna, M., Soemantri, A., van de Vijver, D. A. M. C., Osterhaus, A. D. M. E., & Martina, B. E. E. (2011) · Journal of Clinical Virology · doi:10.1016/j.jcv.2011.09.028 · Cited by 55

Coagulation and morbidity in treated HIV infection

Funderburg, N., & Lederman, M. M. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.03.012 · Cited by 54

Can early therapy reduce inflammation?

Utay, N. S., & Sereti, I. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000020 · Cited by 54

Prognostic Value of Vitamin D Level for All-cause Mortality, and Association With Inflammatory Markers, in HIV-infected Persons

Shepherd, L. C., Souberbielle, J., Bastard, J., Fellahi, S., Capeau, J., Reekie, J., Reiss, P., Blaxhult, A., Bickel, M., Leen, C. L. S., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu074 · Cited by 55

Human Immunodeficiency Virus and Aging in the Era of Effective Antiretroviral Therapy

Epps, P. V., & Kalayjian, R. C. (2017) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2017.07.007 · Cited by 56

Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression

Gisslén, M., Keating, S. M., Spudich, S., Arechiga, V. M., Stephenson, S., Zetterberg, H., Germanio, C. D., Blennow, K., Fuchs, D., Hagberg, L., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250987 · Cited by 54

GeGen QinLian decoction alleviate influenza virus infectious pneumonia through intestinal flora

Deng, L., Shi, Y., Liu, P., Wu, S., Lv, Y., Xu, H., & Chen, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111896 · Cited by 54

Cellular and molecular insights into incomplete immune recovery in HIV/AIDS patients

Yan, L., Xu, K., Xiao, Q., Tuo, L., Luo, T., Wang, S., Yang, R.-D., Zhang, F., & Yang, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1152951 · Cited by 52

Sex differences in soluble markers vary before and after the initiation of antiretroviral therapy in chronically HIV-infected individuals

Krebs, S. J., Slike, B. M., Sithinamsuwan, P., Allen, I. E., Chalermchai, T., Tipsuk, S., Phanuphak, N., Jagodzinski, L. L., Kim, J. H., Ananworanich, J., et al. (2016) · AIDS · doi:10.1097/qad.0000000000001096 · Cited by 53

Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV

Nou, E., Lu, M. T., Looby, S. E. D., Fitch, K. V., Kim, E. A., Lee, H., Hoffmann, U., Grinspoon, S. K., & Lo, J. (2015) · AIDS · doi:10.1097/qad.0000000000000946 · Cited by 53

Chronic HIV disease and activation of the coagulation system

Baker, J. V. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.08.016 · Cited by 52

The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antiretroviral therapy

Koethe, J. R., Grome, H. N., Jenkins, C. A., Kalams, S. A., & Sterling, T. R. (2015) · AIDS · doi:10.1097/qad.0000000000000893 · Cited by 55

Plasma levels of cytokines and chemokines and the risk of mortality in HIV-infected individuals

French, M. A., Cozzi‐Lepri, A., Arduino, R. C., Johnson, M. A., Achhra, A. C., & LANDAY, A. L. (2015) · AIDS · doi:10.1097/qad.0000000000000618 · Cited by 51

Increased inflammation but similar physical composition and function in older-aged, HIV-1 infected subjects

Wallet, M. A., Buford, T. W., Joseph, A.-M., Sankuratri, M., Leeuwenburgh, C., Pahor, M., Manini, T. M., Sleasman, J. W., & Goodenow, M. M. (2015) · BMC Immunology · doi:10.1186/s12865-015-0106-z · Cited by 52

During Stably Suppressive Antiretroviral Therapy Integrated HIV-1 DNA Load in Peripheral Blood is Associated with the Frequency of CD8 Cells Expressing HLA-DR/DP/DQ

Ruggiero, A., Spiegelaere, W. D., Cozzi‐Lepri, A., Kiselinova, M., Pollakis, G., Beloukas, A. I., Vandekerckhove, L., Strain, M. C., Richman, D. D., Phillips, A. N., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.07.025 · Cited by 49

HIV, Combination Antiretroviral Therapy, and Vascular Diseases in Men and Women

Kovács, L., Kress, T. C., & de Chantemèle, E. J. B. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.10.017 · Cited by 49

Chronic immune activation in common variable immunodeficiency (CVID) is associated with elevated serum levels of soluble CD14 and CD25 but not endotoxaemia

Litzman, J., Nechvátalová, J., Xu, J., Tichá, O., Vlková, M., & Hel, Z. (2012) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2012.04655.x · Cited by 49

Different biological significance of sCD14 and LPS in HIV-infection: Importance of the immunovirology stage and association with HIV-disease progression markers

Romero-Sánchez, M. C., González‐Serna, A., Pacheco, Y. M., Ferrando‐Martínez, S., Machmach, K., García-García, M., Álvarez‐Ríos, A. I., Vidal, F., Leal, M., & Ruíz-Mateos, E. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.06.008 · Cited by 49

Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressors

Far, M. E., Kouassi, P., Sylla, M., Zhang, Y., Fouda, A. E., Fabre, T., Goulet, J.-P., van Grevenynghe, J., Lee, T., Singer, J., et al. (2016) · Scientific Reports · doi:10.1038/srep22902 · Cited by 52

Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection

Carrico, A. W., Cherenack, E. M., Roach, M. E., Riley, E. D., Oni, O., Dilworth, S. E., SHOPTAW, S. J., Hunt, P. W., Roy, S., Pallikkuth, S., et al. (2018) · AIDS · doi:10.1097/qad.0000000000001751 · Cited by 49

Frontline Science: Plasma and immunoglobulin G galactosylation associate with HIV persistence during antiretroviral therapy

Vadrevu, S. K., Trbojević‐Akmačić, I., Kossenkov, A. V., Colomb, F., Giron, L. B., Anzurez, A., Lynn, K., Mounzer, K., LANDAY, A. L., Kaplan, R. C., et al. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3hi1217-500r · Cited by 49

Levels of Soluble CD14 and Tumor Necrosis Factor Receptors 1 and 2 May Be Predictive of Death in Severe Coronavirus Disease 2019

Bowman, E., Cameron, C., Avery, A., Gabriel, J., Kettelhut, A., Hecker, M. T., Sontich, C. U., Tamilselvan, B., Nichols, C. N., Richardson, B., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa744 · Cited by 50

Effects of Switching From Efavirenz to Raltegravir on Endothelial Function, Bone Mineral Metabolism, Inflammation, and Renal Function

Gupta, S. K., Mi, D., Moe, S. M., Dubé, M. P., & Liu, Z. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182a97c39 · Cited by 48

Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns

Falasca, F., Carlo, D. D., Vito, C. D., Bon, I., d’Ettorre, G., Fantauzzi, A., Mezzaroma, I., Fimiani, C., Re, M. C., Vullo, V., et al. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2676-2 · Cited by 48

French 2013 guidelines for antiretroviral therapy of HIV‐1 infection in adults

Hoen, B., Bonnet, F., Delaugerre, C., Delobel, P., Goujard, C., L’Hénaff, M., Persiaux, R., Rey, D., Rouzioux, C., Taburet, A., et al. (2014) · Journal of the International AIDS Society · doi:10.7448/ias.17.1.19034 · Cited by 47

Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity

Bastard, J., Fellahi, S., Couffignal, C., Raffi, F., Gras, G., Hardel, L., Sobel, A. T., Leport, C., Fardet, L., Capeau, J., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv036 · Cited by 47

Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors

Castley, A. S. L., Williams, L., JAMES, I. R., Guelfi, G., Berry, C., & Nolan, D. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158169 · Cited by 47

Association Between Depressive Disorders and Incident Acute Myocardial Infarction in Human Immunodeficiency Virus–Infected Adults

Khambaty, T., Stewart, J. C., Gupta, S. K., Chang, C.-C. H., Bedimo, R., Budoff, M. J., Butt, A. A., Crane, H. M., Gibert, C. L., Leaf, D. A., et al. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.2716 · Cited by 47

Intestinal Damage and Inflammatory Biomarkers in Human Immunodeficiency Virus (HIV)–Exposed and HIV-Infected Zimbabwean Infants

Prendergast, A. J., Chasekwa, B., Rukobo, S., Govha, M., Mutasa, K., Ntozini, R., & Humphrey, J. H. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix367 · Cited by 47

Distinct inflammation-related proteins associated with T cell immune recovery during chronic HIV-1 infection

Wan, L.-Y., Huang, H.-H., Zhen, C., Chen, S., Song, B., Cao, W., Shen, L., Zhou, M., Zhang, X.-C., Xu, R., et al. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2150566 · Cited by 46

Immune Activation Response in Chronic HIV-Infected Patients: Influence of Hepatitis C Virus Coinfection

Márquez-Coello, M., Cores, P. R., De, M. M., Martín-Aspas, A., Cárdenas, M. J. S., Guerrero, F., Fernández-Gutiérrez, C., & González, J. A. G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119568 · Cited by 46

Circulating Interleukin-6, Soluble CD14, and Other Inflammation Biomarker Levels Differ Between Obese and Nonobese HIV-Infected Adults on Antiretroviral Therapy

Koethe, J. R., Dee, K., Bian, A., Shintani, A., Turner, M. M., Bebawy, S. S., Sterling, T. R., & Hulgan, T. (2013) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2013.0016 · Cited by 48

Biomarkers of Inflammation and Coagulation Are Associated With Mortality and Hepatitis Flares in Persons Coinfected With HIV and Hepatitis Viruses

Andrade, B. B., Hullsiek, K. H., Boulware, D. R., Rupert, A. W., French, M. A., Ruxrungtham, K., Montes, M., Price, H., Barreiro, P., Audsley, J., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit033 · Cited by 46

Can Probiotics Reduce Inflammation and Enhance Gut Immune Health in People Living with HIV: Study Designs for the Probiotic Visbiome for Inflammation and Translocation (PROOV IT) Pilot Trials

Kim, C. J., Walmsley, S. L., Raboud, J., Kovacs, C., Coburn, B. A., Rousseau, R. K., Reinhard, R. J., Rosenes, R., & Kaul, R. (2016) · HIV Clinical Trials · doi:10.1080/15284336.2016.1184827 · Cited by 46

Mucosal Regulatory T Cells and T Helper 17 Cells in HIV-Associated Immune Activation

Pandiyan, P., Younes, S., Ribeiro, S. P., Talla, A., McDonald, D. J., Bhaskaran, N., Levine, A. D., Weinberg, A., & Sékaly, R. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00228 · Cited by 47

Microbial Translocation and Inflammation Occur in Hyperacute Immunodeficiency Virus Infection and Compromise Host Control of Virus Replication

Ericsen, A. J., Lauck, M., Mohns, M. S., DiNapoli, S. R., Mutschler, J. P., Greene, J., Weinfurter, J. T., Lehrer-Brey, G., Prall, T. M., Gieger, S. M., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1006048 · Cited by 45

Differential recognition of HIV-stimulated IL-1β and IL-18 secretion through NLR and NAIP signalling in monocyte-derived macrophages

Triantafilou, K., Ward, C. J. K., Czubala, M. A., Ferris, R. G., Koppe, E. L., Haffner, C. D., Piguet, V., Patel, V. K., Amrine‐Madsen, H., Modis, L. K., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009417 · Cited by 45

Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study

Abraham, A. G., Darilay, A. T., McKay, H., Margolick, J. B., Estrella, M. M., Palella, F. J., Bolan, R., Rinaldo, C. R., & Jacobson, L. P. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv159 · Cited by 45

HIV and aging

Hunt, P. W. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000072 · Cited by 47

Rate of AIDS Progression Is Associated with Gastrointestinal Dysfunction in Simian Immunodeficiency Virus–Infected Pigtail Macaques

Canary, L., Vinton, C. L., Morcock, D. R., Pierce, J. B., Estes, J. D., Brenchley, J. M., & Klatt, N. R. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202319 · Cited by 45

The Association of Human Cytomegalovirus with Biomarkers of Inflammation and Immune Activation in HIV-1-Infected Women

Lurain, N. S., Hanson, B. A., Hotton, A., Weber, K. M., Cohen, M. H., & LANDAY, A. L. (2015) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2015.0169 · Cited by 46

Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial

Villar, S. S., Sainz, T., Ma, Z.-M., Utay, N. S., Chun, T., Mann, S. K., Kashuba, A. D. M., Siewe, B. T., Albanese, A. P., Troia-Cancio, P. V., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005381 · Cited by 46

Distinct inflammatory profiles in HIV-infected individuals under antiretroviral therapy using cannabis, cocaine or cannabis plus cocaine

de Castro, F. D. O. F., Silva, J. M., Dorneles, G. P., Barros, J. B. D. S., Ribeiro, C. B., Noronha, I. H., Barbosa, G. R., Souza, L. C. S., Guilarde, A. O., Pereira, A. J. C. S., et al. (2019) · AIDS · doi:10.1097/qad.0000000000002296 · Cited by 47

Simian Immunodeficiency Virus Infection of Chimpanzees (Pan troglodytes) Shares Features of Both Pathogenic and Non-pathogenic Lentiviral Infections

Greenwood, E. J. D., Schmidt, F., Kondova, I. I., Niphuis, H., Hodara, V. L., Clissold, L., McLay, K., Guerra, B., Redrobe, S. P., Giavedoni, L. D., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005146 · Cited by 44

Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trial

Cozzi‐Lepri, A., French, M. A., Baxter, J., Okhuysen, P. C., Plana, M., Neuhaus, J., & LANDAY, A. L. (2011) · AIDS · doi:10.1097/qad.0b013e3283471f10 · Cited by 44

Causes of death among Danish HIV patients compared with population controls in the period 1995–2008

Helleberg, M., Kronborg, G., Larsen, C. S., Pedersen, G., Pedersen, C. D., Gerstoft, J., & Obel, N. (2012) · Infection · doi:10.1007/s15010-012-0293-y · Cited by 44

Predict Mortality in

(2016)

High Soluble CD14 Levels at Primary HIV-1 Infection Predict More Rapid Disease Progression

Krastinova, E., Lécuroux, C., Leroy, C., Seng, R., Cabie, A., Rami, A., Venet, A., Meyer, L., & Goujard, C. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv145 · Cited by 40

Elevated Levels of Serum-Soluble CD14 in Human Immunodeficiency Virus Type 1 (HIV-1) Infection: Correlation to Disease Progression and Clinical Events

Lien, E., Aukrust, P., Sundan, A., Müller, F., Frøland, S. S., & Espevik, T. (1998) · Blood · doi:10.1182/blood.v92.6.2084 · Cited by 172

Association of Plasma Soluble Vascular Cell Adhesion Molecule-1 and sCD14 With Mortality in HIV-1–Infected West African Adults With High CD4 Counts

Affi, R., Gabillard, D., Dunyach‐Remy, C., Ntakpe, J.-B., Moh, R., Badjé, A., Kouamé, G. M., Karcher, S., Carrou, J. L., Danel, C., et al. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002533 · Cited by 11

Study of the plasma levels of soluble CD14 in HIV infected patients

Maes, N. (2012) · Document Server@UHasselt (UHasselt)